Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › FFA1 (GPR40) as a therapeutic target for neural angiogenesis diseases or disorders

FFA1 (GPR40) as a therapeutic target for neural angiogenesis diseases or disorders

US Patent 11583528 · Granted Feb 21, 2023

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

ApoM-Fc fusion proteins for treating lung diseases2025
Resonance Raman spectroscopy for evaluating mitochondrial function2025
Methods for treatment of complications of prematurity comprising administration 2016
Method and product for treatment and/or prevention of complications of prematuri2013
Methods for decreasing risk of complications of prematurity using IGF-I and its 2010
Determination of risk and treatment of complications of prematurity2006
Inhibition of neovascularization using vegf-specific oligonucleotides1998
Inhibition of neovascularization using VEGF-specific oligonucleotides1998
Inhibition of neovascularization using VEGF-specific oligonucleotides1998